TORONTO, ONTARIO--(Marketwired - Dec. 22, 2015) - Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK:SPRWF)(CSE:SL) is pleased to announce that the Company has continued (the "Continuance") out of the jurisdiction of the Business Corporations Act (British Columbia) and into the jurisdiction of the Canada Business Corporations Act (the "CBCA") and has adopted By-Law No. 1. The Continuance took place in accordance with the annual and special meeting of shareholders held on December 18, 2015 where the shareholders of the Company approved such continuance. The Company is now a Canadian federal company.
Copies of the certificate of continuance and By- Law No. 1 have been filed under the Company's profile at www.sedar.com.
About Supreme
Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme's flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.
Contact Information:
John Fowler
(416) 630-7272
info@supreme.ca
www.supreme.ca